Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Chemokines and chemokine receptors in multiple sclerosis.
PDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.
Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.
Emerging role of interleukin-22 in autoimmune diseases.
Monomethylfumarate reduces in vitro migration of mononuclear cells.
Evaluation of the effects of reflexology on quality of life and symptomatic relief in multiple sclerosis patients with moderate to severe disability; a pilot study.
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase.
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.
Automated detection of white matter and cortical lesions in early stages of multiple sclerosis.
Mast cells on the mind: new insights and opportunities.
Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
Optimization of electron microscopy for human brains with long-term fixation and fixed-frozen sections.
The essential role of t cells in multiple sclerosis: A reappraisal.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes.
Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme CYP24A1 in multiple sclerosis.
The development of myelin repair agents for treatment of multiple sclerosis: Progress and challenges.
Knee muscle strength in multiple sclerosis: relationship with gait characteristics.
The top clinical trial opportunities in therapeutic apheresis and neurology.
Blockade of CD127 Exerts a Dichotomous Clinical Effect in Marmoset Experimental Autoimmune Encephalomyelitis.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
New treatments for multiple sclerosis: at what long-term risk?
CXCL13 antibody for the treatment of autoimmune disorders.
The Parallel Analysis of Phase Sensitive Inversion Recovery (PSIR) and Double Inversion Recovery (DIR) Images Significantly Improves the Detection of Cortical Lesions in Multiple Sclerosis (MS) since Clinical Onset.
Evaluation of the Effect of Progressive Relaxation Exercises on Fatigue and Sleep Quality in Patients with Multiple Sclerosis.
Pages
« first
‹ previous
…
336
337
338
339
340
341
342
343
344
…
next ›
last »